Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine versus risperidone for autism
IRCT201204037202N5Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of memantine and risperidone in Autism Spectrum Disorder (ASD) (2 arms), sponsored by Tehran University of Medical Sciences. Started Jun 2012; status: completed.
02
Drugs
memantinerisperidone
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on IRCT201204037202N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201204037202N5.